SP-MHCI-0754-3

HIV 1 group M subtype B (isolate BH10) gp160 314-322, GRAFVTIGK

US$507.00

In stock

Description

About HIV 1 group M subtype B (isolate BH10) gp160 314-322, GRAFVTIGK

The Human immunodeficiency virus (HIV) type 1 group M subtype B (isolate BH10) Envelope glycoprotein gp160 Peptide (IEDB: 302918) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Envelope glycoprotein Peptide, H-GRAFVTIGK-OH (Uniprot: P03375 aa: 314-322) from JPT is produced under strict quality control and quality management.

HIV 1 group M subtype B (isolate BH10) gp160 314-322, GRAFVTIGK - Specifications

  • Peptide sequence: H-GRAFVTIGK-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): AIDS (HIV)
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Request a Quote for you custom antigen peptide!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for HIV 1 group M subtype B (isolate BH10) gp160 314-322, GRAFVTIGK

References:
Read References with JPT’s Antigen Peptides
HIV 1 group M subtype B (isolate BH10) gp160 314-322, GRAFVTIGK has been described in:
Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies., J Clin Invest, 1996 (PMID: 8981922)
Modulation at multiple anchor positions of the peptide specificity of HLA-B27 subtypes differentially associated with ankylosing spondylitis., Arthritis Rheum, 1999 (PMID: 10513815)
Immunological monitoring during combination of patient-oriented peptide vaccination and estramustine phosphate in patients with metastatic hormone refractory prostate cancer., Prostate, 2004 (PMID: 15129427)

Documentation

Documentation for HIV 1 group M subtype B (isolate BH10) gp160 314-322, GRAFVTIGK

Properties

Properties of HIV 1 group M subtype B (isolate BH10) gp160 314-322, GRAFVTIGK

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: AIDS (HIV)
Layout: Freeze-dried in glass vial
Organism: Human immunodeficiency virus (HIV)
Protein Name: Envelope glycoprotein
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to HIV 1 group M subtype B (isolate BH10) gp160 314-322, GRAFVTIGK

Information Values
Sequence: H-GRAFVTIGK-OH
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote